Kate Madden Yee[email protected]Health Topics3 ways the U.S. went wrong with COVID-19 testingThose mistakes include limiting testing to the U.S. Centers for Disease Control and Prevention (CDC) and initially restricting it to a particular set of patients, wrote a team led by Dr. Joshua Sharfstein of Johns Hopkins Bloomberg School of Public Health.March 10, 2020Breast CancerOlder women benefit from genetic breast cancer testingThe study addresses the question of who exactly should undergo breast cancer genetic testing, wrote a team led by Dr. Allison Kurian of Stanford University.March 10, 2020Prostate CancerCould liquid biopsy replace PSA for prostate cancer?The test detects a prostate cancer biomarker that signals the disease is active and could help clinicians better monitor prostate cancer response to treatment, wrote a team led by doctoral candidate Anjui Wu of University College London (UCL) Cancer Institute.March 9, 2020Health TopicsNovel coronavirus infection can take 5 days to manifestThe findings support recommendations from the U.S. Centers for Disease Control and Prevention (CDC) stating that patients should be actively monitored for 14 days after an exposure to the virus, wrote a team led by Stephen Lauer, PhD, of Johns Hopkins Bloomberg School of Public Health.March 9, 2020Breast CancerStudy urges broader genetic testing of breast cancer patientsThe National Comprehensive Cancer Network's (NCCN) current guidelines for genetic testing recommend it for women younger than 46 who are diagnosed with breast cancer, regardless of family history or cancer subtype. But expanding the age range for genetic testing would help identify more women with mutations that make them vulnerable, concluded first author Dr. Siddhartha Yadav, a hematology-oncology fellow at the Mayo Clinic in Rochester, MN, and colleagues.March 3, 2020CollaborationCould a 5th 'vital sign' curb the spread of COVID-19?A typical patient evaluation includes an assessment of temperature, heart rate, respiratory rate, and blood pressure. But in the context of COVID-19, adding travel history is key, wrote a research pair led by Dr. Trish Perl, chief of the division of infectious diseases at the University of Texas Southwestern Medical Center.March 2, 2020Health TopicsRecovered COVID-19 patients may still test positiveThe findings suggest that "current criteria for hospital discharge or discontinuation of quarantine and continued patient management may need to be reevaluated," wrote a team led by Dr. Lan Lan from Zhongnan Hospital of Wuhan University in China.February 27, 2020Cervical CancerCould cervical cancer be eliminated in 20 years?The findings suggest a way for the U.S. clinical community to actively respond to the World Health Organization's (WHO) 2018 charge to eliminate cervical cancer as a public health problem, wrote a team led by Emily Burger, PhD, of the Harvard T.H. Chan School of Public Health in Boston. The WHO's cervical cancer incidence target is four or fewer cases per 100,000 women-years.February 10, 2020Previous PagePage 4 of 4Top StoriesDiagnostic TechnologiesFDA said no to proficiency testing for LDT qualityInferior tests can pass through proficiency testing, among ways PT falls short for test safety and effectiveness for intended purposes.Policy and RegulationFDA releases LDT final ruleResearch AllianceGSK, Genomics PLC collaborate on polygenic risk score use for clinical trialsCOVID-19Study: Age-related differences in nasal cells offer COVID-19 protectionSponsor ContentVisit our Molecular Diagnostics Community